New vaccine shows potential in preventing recurrence of triple-negative breast cancer

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

What does Biden’s executive order mean for worldwide AI regulation? – Pharmaceutical Technology

The US executive order sends a strong message globally that it is time to move towards AI regulation. Credit: Ascannio via Shutterstock. On October 30,

November 8, 2023

Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – August 9, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”), a clinical-stage biotechnology

August 9, 2024

Researchers probe environmental causes of preterm birth with $2.8M grant

A new grant will help Wayne State University researchers explore the links between bacterial infections, the environmental factors that increase their susceptibility and the risk

October 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.